Science Resources RSS Feeds
|
 |
 |
 |
Survival Current Events | Survival News | 10
|
| Page
10 of
25 |
482 Results |
|
|
|
Sort By:
Page Views | Date |
Avastin dramatically improves response, survival in deadly recurrrent glioblastomas
The targeted therapy Avastin, alone and in combination with the chemotherapy drug CPT-11, significantly increased response rates, progression-free survival times and survival rates in patients with a deadly form of brain cancer that had recurred. view more (2009-09-03)
Taking sharper aim at stomach ulcer bacteria
Scientists are reporting discovery of a much sought after crack in the armor of a common microbe that infects the stomachs of one-sixth of the world's population, causing stomach ulcers and other diseases. view more (2009-10-01)
Severity of diabetes is key determinant of heart transplant success
Having diabetes should not automatically disqualify you from being considered for a heart transplant. view more (2006-11-07)
A low-carb diet may stunt prostate tumor growth
A diet low in carbohydrates may help stunt the growth of prostate tumors, according to a new study led by Duke Prostate Center researchers. view more (2007-11-14)
Managing Colorectal Cancers In The NHS
How best to detect and manage bowel cancer is the subject of the latest issue of EFFECTIVE HEALTH CARE. Colorectal (bowel) cancer is the second most common cause of cancer death in England and Wales. Early detection and good management result in improved survival rates. Improvements have been made in the provision of services and treatment of... view more... (2004-06-28)
New type of drug shows promise in attacking melanoma in an innovative way
An experimental drug that attacks cancer in an entirely new way has shown promise in treating advanced melanoma, delaying progression of the disease and prolonging the lives of patients. view more (2007-09-27)
190 End-Stage Renal Disease Patients Die Each Day: Epogen Usage Questioned
Seminars in Dialysis, a peer-reviewed journal published by Blackwell Publishing, is featuring the much-publicized* controversial editorial authored by Dennis Cotter in its May issue, despite outright rejection from a competitive journal, Dialysis and Transplantation. Cotter asks the important question as to the actual benefit of higher Epogen... view more... (2004-06-11)
Race a factor in receiving transplant treatment for bone marrow cancer but does not affect outcomes
A new study by researchers at The Medical College of Wisconsin Cancer Center Milwaukee, has found that African Americans and whites have identical survival rates after undergoing autologous (self donor) bone marrow transplant treatment for a common cancer of the bone marrow (multiple myeloma). view more (2008-12-09)
Novel 4-drug combination proves safe for lung cancer treatment
The four drug-combination of carboplatin and paclitaxel, with the targeted therapies bevacizumab (Avastin) and cetuximab (Erbitux), is safe and may improve survival for patients with advanced lung cancer, according to a cooperative group study led by The University of Texas M. D. Anderson Cancer Center. view more (2008-11-13)
2 reproductive factors are important predictors of death from ovarian cancer
Researchers from the Centers for Disease Control and Prevention (CDC) found that survival among women with ovarian cancer is influenced by age of menarche and total number of lifetime ovulatory cycles. view more (2009-07-09)
Stem cell transplantation procedure results in long-term survival for amyloidosis patients
Researchers from the Stem Cell Transplant Program and the Amyloid Treatment and Research Program at Boston University Medical Center (BUMC) have found that high-dose chemotherapy and blood stem cell transplantation can result in long-term survival for patients diagnosed with primary systemic light chain (AL) Amyloidosis. view more (2007-08-08)
Advanced-stage ovarian cancer patients with BRCA live longer, may respond better to treatment
Two abstracts underscoring the importance of testing for BRCA1/2 mutations in women with ovarian cancer were presented at this week's Society of Gynecologic Oncologists 39th Annual Meeting on Women's Cancers, by researchers from The University of Texas M. D. Anderson Cancer Center. view more (2008-03-11)
Surgery remans an option for advanced lung cancer
In recent years, oncologists have debated whether patients with a certain type of advanced lung cancer would benefit from surgery. view more (2009-07-27)
Study finds cisplatin less effective than standard treatment for patients with anal cancer
When administered before chemoradiation, the common anti-cancer drug cisplatin neither improved disease-free survival nor reduced the number of colostomies needed when compared to the standard treatment for patients with anal canal cancer, according to a study published in the April 23 issue of the Journal of the American Medical Association. view more (2008-04-23)
Breast cancer more aggressive among obese women
Women with breast cancer have more aggressive disease and lower survival rates if they are overweight or obese, according to findings published in the March 15 issue of Clinical Cancer Research, a journal of the American Association for Cancer Research. view more (2008-03-14)
Survival rates exceed national averages for UCSF heart, liver and lung transplant programs
One-year survival rates for patients receiving heart, liver and lung transplants at UCSF Medical Center exceed national averages at statistically significant levels, according to new data compiled by the Scientific Registry of Transplant Recipients (SRTR). view more (2008-03-03)
International Study Suggests Carboplatin Could Be First-line Chemotherapy Drug For Ovarian Cancer
Results of an international study in this week's issue of THE LANCET suggest that the drug carboplatin could become a first-line chemotherapeutic agent for the treatment of ovarian cancer. Carboplatin was found to be less toxic, although it had no overall survival benefit, compared with other drugs assessed in the study. Ovarian cancer is the... view more... (2002-08-14)
M. D. Anderson study finds dramatic increase in metastatic colon cancer survival
Novel chemotherapy and biological agents for metastatic colorectal cancer, combined with surgical advances in liver resection, have resulted in a dramatic increase in survival for patients with advanced disease. view more (2009-05-27)
Substantial Increase In Survival After Introduction Of Highly Active Antiretroviral Therapy For HIV-1 Infection (p 1267)
Research published in this week's issue of THE LANCET highlights the substantial increased survival for people with HIV-1 since the introduction of highly active antiretroviral therapy (HAART) in 1997. However the study also shows a shift in risk profiles compared with earlier data-people over 45 years no longer appear to have reduced survival... view more... (2003-10-15)
Why kidneys from older donors do not last as long as those from younger individuals
Kidneys from older donors often do not survive long after transplantation because of certain structural dysfunctions that can occur as the kidney ages, according to a study appearing in the January 2009 issue of the Journal of the American Society Nephrology (JASN). view more (2008-09-25)
|
|
| Page
10 of
25 |
482 Results |
|
|
|
Sort By:
Page Views | Date |
|
|
